World Wires · story 5385 · unverified · 1 source(s)

Phathom Pharmaceuticals Initiates Phase 3 Study for VOQUEZNA

Phathom Pharmaceuticals started patient screening in a registrational Phase 3 study evaluating VOQUEZNA for non-erosive GERD.

Open in the desk

Coverage

• Phathom Pharmaceuticals Initiates Phase 3 Study for VOQUEZNA GlobeNewswire: public companies · tier D · clear net · 2026-09-29 12:00 UTC

What this site indexes